Key result
Universal childhood screening for familial hypercholesterolaemia enables early detection and timely lipid-lowering treatment.
Why the study?
Familial hypercholesterolaemia causes lifelong elevation of LDL cholesterol and premature cardiovascular disease, yet the vast majority of affected children and adults remain undiagnosed.
Does population-based childhood screening combining LDL cholesterol measurement with genetic testing enable early diagnosis and treatment of familial hypercholesterolaemia in children?
Does population-based childhood screening combining LDL cholesterol measurement with genetic testing enable early diagnosis and treatment of familial hypercholesterolaemia in children?
Extensive indirect evidence supports the benefit of early detection and lipid-lowering therapy via population-based childhood screening for familial hypercholesterolaemia, despite the lack of randomized trials comparing screened and unscreened populations.
Answers are grounded in this paper and cite their sources.
Supports consideration of childhood FH screening; leaves open need for prospective outcome trials before routine adoption.
Familial hypercholesterolaemia (FH) is among the most common monogenic disorders, affecting at least 1 in 250 individuals. Lifelong elevation of LDL cholesterol from birth can cause accelerated atherosclerosis and premature cardiovascular disease. However, the vast majority of affected children (and adults) remain undiagnosed. Population-based childhood screening, combining LDL cholesterol measurement with genetic testing, enables early diagnosis and treatment. This review summarizes evidence on childhood FH screening, including disease burden, treatment efficacy, diagnostic performance, and economic considerations. Although no randomized trial has compared screened and unscreened populations, extensive indirect evidence supports the benefit of early detection and lipid-lowering therapy.
No takes yet. Share an insight, caveat, or question.
Schlein et al. (2026) conducted a review in Familial hypercholesterolaemia. Population-based childhood screening (LDL cholesterol measurement and genetic testing) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: